← Back to Search

PICTURE-THIS Intervention for Post Intensive Care Recovery

N/A
Recruiting
Led By Leslie P Scheunemann, MD MPH
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients: be ≥50 years old
be admitted from home
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is examining the feasibility and acceptability of a transitional rehabilitation intervention for critical illness survivors and their families. It involves user-testing, assessing the protocol and assessing research activities.

Who is the study for?
This trial is for critical illness survivors over 50 who spent at least 48 hours in ICU, have a life expectancy of over a year, and were admitted from home. It's also for their caregivers aged 21+, who've been supporting since the ICU stay. Healthcare providers involved with these pairs can join too. All participants must speak English and live in Pennsylvania.Check my eligibility
What is being tested?
The study tests PICTURE-THIS, an intervention combining transitional care coordination with activity-based rehabilitation by specialists, to see if it's feasible and acceptable for patients post-critical care and their families.See study design
What are the potential side effects?
Since this trial focuses on rehabilitation methods rather than medication or invasive procedures, traditional side effects are not applicable. However, there may be potential discomforts related to participation such as fatigue or emotional distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 50 years old or older.
Select...
I am coming from my home for treatment.
Select...
I have spent 48 hours or more in an ICU.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Enrollment
Retention
Secondary outcome measures
PROPr

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PICTURE-THIS servicesExperimental Treatment2 Interventions
This group receives a Run-In Phase followed by outpatient transitional care management (up to 8 visits over 3 months), activity-based rehabilitation (up to 10 visits over 3 months), and social support for patients and families (ongoing screening and referral). They will also undergo outcome assessments at discharge, 3 and 6 months.
Group II: Enhanced Usual CareActive Control2 Interventions
Enhanced Usual Care (EUC) control group will rececive a Run-in Phase followed by an informational brochure with regular assessments on the same schedule as the PICTURE-THIS group (i.e., discharge, 3 and 6 months)

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,343,056 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,248 Total Patients Enrolled
Leslie P Scheunemann, MD MPHPrincipal InvestigatorUniversity of Pittsburgh

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently enrolling new participants?

"Per the details given on clinicaltrials.gov, this experiment is currently recruiting participants with enrolment beginning in August of 2023 and ending October 10th of that same year."

Answered by AI

How many individuals are currently receiving treatment through this research trial?

"Affirmative, the clinical trial is recruiting. According to information posted on clinicaltrials.gov, this study was first published on August 9th 2023 and has been updated most recently on October 10th 2023. The team is seeking 100 individuals from a single medical centre for participation in the trial."

Answered by AI
~47 spots leftby Nov 2024